Altered gut microbiome profile in patients with knee osteoarthritis
Frontiers in Microbiology · 12.05.2023 · 14
DOI: 10.3389/fmicb.2023.1153424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 12.05.2023. Verfasst von Xi Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Environmental Health, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
Osteoarthritis (OA) is a kind of chronic, degenerative disorder with unknown causes. In this study, we aimed to improve our understanding of the gut microbiota profile in patients with knee OA.
Methods
16S rDNA gene sequencing was performed to detect the gut microbiota in fecal samples collected from the patients with OA ( n = 32) and normal control (NC, n = 57). Then the metagenomic sequencing was used to identify the genes or functions linked with gut microbial changes at the species level in the fecal samples from patients with OA and NC groups.
Results
The Proteobacteria was identified as dominant bacteria in OA group. We identified 81 genera resulted significantly different in abundance between OA and NC. The abundance of Agathobacter , Ruminococcus , Roseburia , Subdoligranulum , and Lactobacillus showed significant decrease in the OA compared to the NC. The abundance of genera Prevotella_7 , Clostridium , Flavonifractor and Klebsiella were increasing in the OA group, and the families Lactobacillaceae , Christensenellaceae , Clostridiaceae_1 and Acidaminococcaceae were increasing in the NC. The metagenomic sequencing showed that the abundance of Bacteroides stercoris , Bacteroides vulgatus and Bacteroides uniformis at the species level were significantly decreasing in the OA, and the abundance of Escherichia coli , Klebsiella pneumoniae , Shigella flexneri and Streptococcus salivarius were significantly increased in OA.
Discussion
The results of our study interpret a comprehensive profile of the gut microbiota in patients with knee OA and offer the evidence that the cartilage-gut-microbiome axis could play a crucial role in underlying the mechanisms and pathogenesis of OA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Occupational and Environmental Health, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
- Key Laboratory of Trace Elements and Endemic Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, National Health and Family Planning Commission, Xi'an, Shaanxi, China.
- Foot and Ankle Surgery Department, Honghui Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Clinical Research Center for Endemic Disease of Shaanxi Province, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Wu, Y., Liu, Y., Chen, F., Chen, S., Zhang, F., Li, S., Wang, C., Gong, Y., Huang, R., Hu, M., Ning, Y., Zhao, H., & Guo, X. (2023). Altered gut microbiome profile in patients with knee osteoarthritis. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1153424
Vancouver
Wang X, Wu Y, Liu Y, Chen F, Chen S, Zhang F, et al. Altered gut microbiome profile in patients with knee osteoarthritis. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1153424
BibTeX
@article{Wang2023,
author = {Wang, Xi and Wu, Yifan and Liu, Yanli and Chen, Feihong and Chen, Sijie and Zhang, Feiyu and Li, Shujin and Wang, Chaowei and Gong, Yi and Huang, Ruitian and Hu, Minhan and Ning, Yujie and Zhao, Hongmou and Guo, Xiong},
title = {Altered gut microbiome profile in patients with knee osteoarthritis},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1153424}
}
EUVIMED